Topics
Glioblastoma | Etiopathogenesis | Noncoding RNA
Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Noncoding RNA
2024
Leili FR, Shali N, Sheibani M, Jafarian MJ, Pashizeh F, Gerami R,
Iraj F, Lashkarshekan AA.
Detailed
pathological role of non-coding RNAs (ncRNAs) in regulating drug
resistance of glioblastoma, and update.
Pathol
Res Pract. 2024 Sep 12;263:155590. doi:
10.1016/j.prp.2024.155590. PMID:
39326365. Review˰ ˍ
Bagheri-Mohammadi S, Karamivandishi A, Mahdavi SA,
Siahposht-Khachaki A.
New sights on
long non-coding RNAs in glioblastoma: A review of molecular
mechanism.
Heliyon. 2024 Oct 23;10(21):e39744. doi:
10.1016/j.heliyon.2024.e39744. PMID:
39553554. Review. ˍ
2025
Parikh D, Shah M.
Targeting non-coding
RNAs to overcome resistance and improving outcomes in
glioblastoma.
Glob Med Genet. 2025 Sep
10;12(4):100075. doi:
10.1016/j.gmg.2025.100075. PMID:
41451392. Review. ˍ
2026
van de Langerijt KA, Kibria MG, Villa GR, Mineo M.
The
Hallmarks of Glioblastoma: Functional Interplay Between Long
Non-Coding RNAs and RNA-Binding Proteins.
Cells.
2026 Jul 11;15(14):1251. doi:
10.3390/cells15141251. PMID:
42505361. ˍ
Leclerc A, Emery E, Levallet G.
Circulating
miRNAs for glioblastoma monitoring: from biofluid to clinical
decision.
Mol
Ther Oncol. 2026 Jul 28;34(3):201308. doi:
10.1016/j.omton.2026.201308. PMID:
42604142. ˍ
Elemam NM, Sweillam JH, El-Sherif Y, Youssef YA, Ismail HM, Assal
RA, Youness RA.
Long non-coding RNAs
in glioblastoma: from molecular drivers to therapeutic targets.
Front
Immunol. 2026 Aug 7;17:1887815. doi:
10.3389/fimmu.2026.1887815. PMID:
42630738. ˍ